Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2’O-methylation of ribosomal RNA
Neuro-Oncology · 08.12.2023 · 25 (12) · 2191-2206
DOI: 10.1093/neuonc/noad140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 02.08.2023. Verfasst von Hermes Paraqindes und 30 weiteren Autor:innen. Beteiligte Einrichtung: LabEx Dev2CAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université …. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Glioma. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: INCa, French Association pour la Recherche sur les Tumeurs Cérébrales, Ligue Contre le Cancer Auvergne-Rhône-Alpesand the SIRIC program.
Abstract (Originalsprache)
Background
High-grade adult-type diffuse gliomas (HGGs) constitute a heterogeneous group of aggressive tumors that are mostly incurable. Recent advances highlighting the contribution of ribosomes to cancer development have offered new clinical perspectives. Here, we uncovered that isocitrate dehydrogenase (IDH)wt and IDHmut HGGs display distinct alterations of ribosome biology, in terms of rRNA epitranscriptomics and ribosome biogenesis, which could constitute novel hallmarks that can be exploited for the management of these pathologies.
Methods
We analyzed (1) the ribosomal RNA 2’O-ribose methylation (rRNA 2’Ome) using RiboMethSeq and in-house developed bioinformatics tools (https://github.com/RibosomeCRCL/ribomethseq-nfandrRMSAnalyzer) on 3 independent cohorts compiling 71 HGGs (IDHwt n = 30, IDHmut n = 41) and 9 non-neoplastic samples, (2) the expression of ribosome biogenesis factors using medium throughput RT-qPCR as a readout of ribosome biogenesis, and (3) the sensitivity of 5 HGG cell lines to RNA Pol I inhibitors (CX5461, BMH-21).
Results
Unsupervised analysis demonstrated that HGGs could be distinguished based on their rRNA 2’Ome epitranscriptomic profile, with IDHwt glioblastomas displaying the most significant alterations of rRNA 2’Ome at specific sites. In contrast, IDHmut HGGs are largely characterized by an overexpression of ribosome biogenesis factors compared to non-neoplastic tissues or IDHwt glioblastomas. Finally, IDHmut HGG-derived spheroids display higher cytotoxicity to CX5461 than IDHwt glioblastoma, while all HGG spheroids display a similar cytotoxicity to BMH-21.
Conclusions
In HGGs, IDH mutational status is associated with specific alterations of the ribosome biology and with distinct sensitivities to RNA Pol I inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LabEx Dev2CAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon, Centre Léon Bérard, CEDEX 08, Lyon, France.
- Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, Lyon, France.
- Plateforme 3D-ONCO, Université de Lyon, Université Claude Bernard Lyon 1, Inserm U1052, CNRS UMR5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon (CRCL), Lyon, France.
- Hospices Civils de Lyon, Laboratoire de biologie médicale et d'anatomie pathologique, Lyon, France.
- INRIA Grenoble Rhône-Alpes, Montbonnot-Saint-Martin, France.
- Cancer Genomics Platform, Centre de Recherche en Cancérologie de Lyon, CEDEX 08, Lyon, France.
ORCID-Profile: Thiébaud Picart, Emilie Thomas, Alain Viari, David Meyronet, Virginie Marcel, Sébastien Durand
Förderung
- INCa
- French Association pour la Recherche sur les Tumeurs Cérébrales
- Ligue Contre le Cancer Auvergne-Rhône-Alpesand the SIRIC program
Zitieren
APA
Paraqindes, H., Mourksi, N. E. H., Ballesta, S., Hedjam, J., Bourdelais, F., Fenouil, T., Picart, T., Catez, F., Combe, T., Ferrari, A., Kielbassa, J., Thomas, E., Tonon, L., Viari, A., Attignon, V., Carrere, M., Perrossier, J., Giraud, S., Vanbelle, C., …, & Durand, S. (2023). Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2’O-methylation of ribosomal RNA. Neuro-Oncology, 25(12), 2191-2206. https://doi.org/10.1093/neuonc/noad140
Vancouver
Paraqindes H, Mourksi NEH, Ballesta S, Hedjam J, Bourdelais F, Fenouil T, et al. Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2’O-methylation of ribosomal RNA. Neuro-Oncology. 2023;25(12):2191-2206. doi:10.1093/neuonc/noad140
BibTeX
@article{Paraqindes2023,
author = {Paraqindes, Hermes and Mourksi, Nour-El-Houda and Ballesta, Samantha and Hedjam, Jordan and Bourdelais, Fleur and Fenouil, Tanguy and Picart, Thiébaud and Catez, Frédéric and Combe, Théo and Ferrari, Anthony and Kielbassa, Janice and Thomas, Emilie and Tonon, Laurie and Viari, Alain and Attignon, Valéry and Carrere, Marjorie and Perrossier, Jessie and Giraud, Stéphane and Vanbelle, Christophe and Gabut, Mathieu and Bergeron, Danny and Scott, Michelle S and Castro Vega, Luis and Magne, Nathalie and Huillard, Emmanuelle and Sanson, Marc and Meyronet, David and Diaz, Jean-Jacques and Ducray, François and Marcel, Virginie and Durand, Sébastien},
title = {Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2’O-methylation of ribosomal RNA},
journal = {Neuro-Oncology},
year = {2023},
volume = {25},
number = {12},
pages = {2191--2206},
doi = {10.1093/neuonc/noad140}
}
EUVIMED